Identification of novel compounds from Olea Europaea targeting hDus2 as potential anticancer agents: a molecular docking and molecular dynamics study
Frontiers in Oncology · 05.11.2026 · 16
DOI: 10.3389/fonc.2026.1845700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 05.11.2026. Verfasst von Monika Mukhija und 6 weiteren Autor:innen. Beteiligte Einrichtung: Peptide Chemistry Lab, School of Physical Sciences, Jawaharlal Nehru University, New Delhi, India. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Leukemia, a type of blood cancer, ranks among the top causes of cancer-related fatalities. Human tRNA-dihydrouridine synthase 2 (hDus2) catalyzes the conversion of uridine to dihydrouridine in the tRNA and is overexpressed in cancer cells, facilitating the translational process required for cancer cell growth. Inhibition of hDus2 reduces cancer cell growth and viability while increasing apoptosis sensitivity under stress, making it an excellent cancer target. Olea Europaea is known to be abundant in flavonoids, polyphenols, vitamins, and antioxidants, and shows immense potential in providing health benefits. The varied properties of these compounds are very significant in the prevention of disorders such as Alzheimer’s and Cancer. Methodology Olea Europaea extract was tested for anti-cancer activity, followed by identification of potential leads using in silico methods. The compounds from the OliveNet database were screened against the hDus2 enzyme. The identified compounds were further validated using Molecular Dynamics (MD) Simulation.
Results
Molecular docking studies with the Glide module revealed that several compounds showed high affinity for hDus2. The top five compounds out of six hundred seventy six compounds were selected for molecular dynamics simulations to study their structural stability and conformational dynamics in the presence of solvent molecules.
Conclusion
Binding free energy calculations revealed that all complexes were stable, with P166 and P161 exhibiting the highest binding potential against hDus2. These findings lay the foundation for the development of novel anti-cancer therapeutics targeting leukemia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Peptide Chemistry Lab, School of Physical Sciences, Jawaharlal Nehru University, New Delhi, India.
- Centre for Biodesign, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
- Population and Quantitative Health Sciences, Case Western University, Cleveland, OH, United States.
- Department of Pharmaceutical Chemistry, Bombay College of Pharmacy, Mumbai, Maharashtra, India.
Zitieren
APA
Mukhija, M., Chandra, A., Devi, K., Chaudhuri, S., Bhattacharya, B., Sharma, T., & Goel, V. K. (2026). Identification of novel compounds from Olea Europaea targeting hDus2 as potential anticancer agents: a molecular docking and molecular dynamics study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1845700
Vancouver
Mukhija M, Chandra A, Devi K, Chaudhuri S, Bhattacharya B, Sharma T, et al. Identification of novel compounds from Olea Europaea targeting hDus2 as potential anticancer agents: a molecular docking and molecular dynamics study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1845700
BibTeX
@article{Mukhija2026,
author = {Mukhija, Monika and Chandra, Anshuman and Devi, Kanika and Chaudhuri, Susmita and Bhattacharya, Brooke and Sharma, Tripti and Goel, Vijay Kumar},
title = {Identification of novel compounds from Olea Europaea targeting hDus2 as potential anticancer agents: a molecular docking and molecular dynamics study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1845700}
}
EUVIMED